Emerging Market for Clinical Trials in Russia - Curbs on New Drug Approval Timelines and Registration Fees Encourage the Emergence of a Major Global Player - GBI Research Reports

Emerging Market for Clinical Trials in Russia - Curbs on New Drug Approval Timelines and Registration Fees Encourage the Emergence of a Major Global Player

Emerging Market for Clinical Trials in Russia - Curbs on New Drug Approval Timelines and Registration Fees Encourage the Emergence of a Major Global Player - GBI Research Reports
Emerging Market for Clinical Trials in Russia - Curbs on New Drug Approval Timelines and Registration Fees Encourage the Emergence of a Major Global Player
Published Jul 01, 2011
89 pages — Published Jul 01, 2011
Price US$ 3,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

GBI Research has released its latest report, Emerging Market for Clinical Trials in Russia - Curbs on New Drug Approval Timelines and Registration Fees Encourage the Emergence of a Major Global Player that provides key data, information and analysis of the major trends and issues affecting the Clinical Trial market in Russia. The report provides a comprehensive insight of reasons for outsourcing clinical trials to Russia. The report also provides a detailed analysis of Russian clinical trial market structure. Analysis of major companies and countries which sponsor clinical trials in Russia is provided. Patient population analysis is done to highlight the types of diseased population available for conducting clinical trials in Russia. Opinion of industry experts has been incorporated in various parts of the report to emphasize the importance of various factors that affect the clinical trial market scenario in Russia.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GBI Researchs team of industry experts.

Scope

The scope of the report includes -
- The need for outsourcing clinical trials to Russia
- Major companies and countries which sponsor clinical trials in Russia
- Trends in clinical trial registration in Russia
- Analysis of the key drivers and restraints that are impacting the growth of Clinical trial market in Russia
- Qualitative analysis of the key Infrastructural facilities present for conducting clinical trials in Russia
- Analysis of new federal law On circulation of medicine and its impact on clinical trials market in Russia.
- Study of 11 key CROs operating in Russia.

Reasons to buy

The report will enhance your decision making capability. It will allow you to -
- Compare the key capabilities of major clinical trial service providers with your requirements and optimize your R&D costs
- Develop market entry and market expansion strategies by identifying the key drivers and challenges in Russian market
- Develop effective strategies to maximize the advantages in Russia through the understanding of the regulatory environment
- Understand the regulatory structure in Russia and key documents required to register clinical trial in Russia
- Gain knowledge about the major indications for which clinical trials can be conducted in Russia

  
Source:
Document ID
GBIHC102MR
Industry
Format:
PDF Adobe Acrobat
Buy Now

GBI Research Reports—GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leaders' insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs.

About the Author


Cite this Report

  
MLA:
GBI Research Reports. "Emerging Market for Clinical Trials in Russia - Curbs on New Drug Approval Timelines and Registration Fees Encourage the Emergence of a Major Global Player" Jul 01, 2011. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Emerging-Market-for-Clinical-Trials-in-Russia-Curbs-on-New-Drug-Approval-Timelines-and-Registration-Fees-Encourage-the-Emergence-of-a-Major-Global-Player-2115-268>
  
APA:
GBI Research Reports. (2011). Emerging Market for Clinical Trials in Russia - Curbs on New Drug Approval Timelines and Registration Fees Encourage the Emergence of a Major Global Player Jul 01, 2011. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Emerging-Market-for-Clinical-Trials-in-Russia-Curbs-on-New-Drug-Approval-Timelines-and-Registration-Fees-Encourage-the-Emergence-of-a-Major-Global-Player-2115-268>
  
US$ 3,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.